Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice

International Journal of Pharmaceutics

Volumn 397, Issue 1-2, 2010, Pages 194-200

  Mondal, Nita ^a   Halder, Kamal Krishna ^b   Kamila, Madan Mohan ^a   Debnath, Mita Chatterjee ^b   Pal, Tapan K ^a   Ghosal, Saroj K ^a   Sarkar, Bharat R ^c   Ganguly, Shantanu ^c  

^a JADAVPUR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c Regional Centre   (India)

Author keywords

Biodistribution; Letrozole; PLGA nanoparticles; Technetium 99m; Tumor uptake

Indexed keywords

LETROZOLE; NANOPARTICLE; POLYGLACTIN; SOLVENT; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; DRUG UPTAKE; DRUG URINE LEVEL; EHRLICH ASCITES TUMOR; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; AROMATASE INHIBITORS; CARCINOMA, EHRLICH TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FREEZE DRYING; LACTIC ACID; MICE; NANOPARTICLES; NITRILES; PARTICLE SIZE; PENTETIC ACID; POLYGLYCOLIC ACID; RATS; TECHNETIUM; TISSUE DISTRIBUTION; TRIAZOLES;

EID: 77955982514     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.06.049     Document Type: Article

References (25)

1. Allemann E., Gurney R., Doelker E. Drug-loaded nanoparticles-preparation methods and drug targeting tissues. Eur. J. Pharm. Biopharm. 1993, 39:173.
2. Allen T.M., Hansen C.B., Guo L.S.S. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta 1993, 1150:9-16.
3. Brannon-Peppas L. Recent advances on the use of biodegradable micro particles and nanoparticles in controlled drug delivery. Int. J. Pharm. 1995, 116:1-9.
4. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 2002, 54:631-651.
5. Brown K. Breast cancer chemoprevention: risk-benefit effects of the antiestrogen tamoxifen. Expert Opin. Drug Saf. 2002, 1:253-267.
6. Cohen M.H., Johnson J.R., Li N., Chen G., Pazdur R. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Clin. Can. Res. 2002, 8:665-669.
7. Dillen K., Vandervoort J., Mooter G.V., Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticle. Int. J. Pharm. 2006, 314:72-82.
8. Halder K.K., Mandal B., Chatterjee Debnath M., Bera H., Ghosh L.K., Gupta B.K. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. J. Drug Target. 2008, 16:311-320.
9. Hughes G.A. Nanostructure mediated drug delivery. Nanomedicine 2005, 1:22-30.
10. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co glycolide) (PLGA) devices. Biomaterials 2000, 21:2475-2490.
11. Jin C., Bai L., Wu H., Liu J., Guo G., Chen J. Paclitaxel-loaded poly(d,l-lactide-co-glycolide) nanoparticles for radiotherapy in hypoxic human tumor cells in vitro. Cancer Biol. Ther. 2008, 7:911-916.
12. Konan Y.N., Gurney R., Allemann E. Preparation and characterization of sterile and freeze-dried sub-200nm nanoparticles. Int. J. Pharm. 2002, 233:239-252.
13. Long B.J., Jelovac D., Handratta V. Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model. J. Natl. Cancer Inst. (Bethesda) 2004, 96:456-465.
14. Mainardes R.M., Evangelista R.C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int. J. Pharm. 2005, 290:137-144.
15. Miller W.R. Aromatase inhibitors in breast cancer. Cancer Treat. Rev. 1997, 23:171-187.
16. Mondal N., Pal T.K., Ghosal S.K. Development, physical characterization, micromeritics and in vitro release kinetics of letrozole loaded biodegradable nanoparticles. Pharmazie 2008, 63:361-365.
17. Reddy L.H., Sharma R.K., Chutani K., Mishra A.K., Murthy R.S.R. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. J. Control. Release 2005, 105:185-198.
18. 99mTc] technetium labeled liposomes in normal and tumor bearing rats. Biochem. Soc. Trans. 1977, 5:290-291.
19. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001, 70:1-20.
20. Vauthier C., Dubernet C., Chauvierre C., Brigger I., Couvreur P. Drug delivery to resistant tumors: the potential of poly (alkyl cyanoacrylate) nanoparticles. J. Control. Release 2003, 93:151-160.
21. Vogel V.G. Reducing the risk of breast cancer with tamoxifen in woman at increased risk. J. Clin. Oncol. 2001, 19:87S-92S.
22. Weir H.K., Thun M.J., Hankey B.F., Ries L.A.G., Howe H.L., Wingo P.A., Jemal A., Ward E., Anderson R.N. Annual report to the nation on the status of cancer, 1975-2000, featuring the use of surveillance data for cancer prevention and control. J. Nat. Cancer Inst. (Bethesda) 2003, 95:1276-1299.
23. Yamaguchi K., Anderson J.M. In vivo biocompatibility studies of medisorb 65/36 dl-lactide/glycolide copolymer microspheres. J. Control. Release 1993, 24:81-93.
24. Yan F., Zhang C., Zheng Y., Mei L., Tang L., Song C., Sun H., Huang L. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomed. Nanotech. Biol. Med. 2010, 6:170-178.
25. Yuan F., Leuning M., Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in human tumor xenograft. Cancer Res. 1994, 54:3352-3356.